Patents by Inventor Michael STUBBINGTON

Michael STUBBINGTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210327544
    Abstract: An interactive visualization system is disclosed herein. The system includes a data source, user input device, processor, and display. The data source obtains a B cell receptor and/or T cell receptor data source. The user input device receives a user selected parameter under which to analyze the data set. The processor identifies a clonotype group in the data set using the parameter, identifies subclonotypes within the clonotype group (wherein each identified subclonotype comprises cells having identical V(D)J transcripts), and processes the data to define a visualization model that can display a compressed view of the identified clonotype group. The display renders a visualization of said data set according to said visualization model. The visualization displays the clonotype group by identified subclonotype.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 21, 2021
    Inventors: David Jaffe, Sreenath Krishnan, Wyatt McDonnell, Michael Stubbington
  • Patent number: 11131664
    Abstract: The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing and analyte characterization from one or more cells. Such polynucleotide processing may be useful for a variety of applications, including generation of labeled macromolecules, including major mistocompatability complex (MHC) molecules, dextramers, etc. Labeled macromolecules may be generated using an in vitro transcription reaction. Labeled macromolecules may be generated in one or more partitions.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: September 28, 2021
    Assignee: 10X GENOMICS, INC.
    Inventors: Katherine Pfeiffer, Sarah Taylor, Michael Stubbington
  • Patent number: 11002731
    Abstract: The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing and antigen screening. Polynucleotide processing may be useful for a variety of applications. Antigen screening may comprise the use of one or more engineered cells. Engineered cells may be useful for characterizing one or more analytes including, for example, a polypeptide antigen.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: May 11, 2021
    Assignee: 10X GENOMICS, INC.
    Inventors: Katherine Pfeiffer, Sarah Taylor, Michael Stubbington
  • Publication number: 20210079383
    Abstract: Featured are devices, systems, and methods of use for profiling a T cell receptor (TCR) from individual T cells or a population of T cells, and the use of profiling antigen-presenting cells (pAPCs) in such methods, compositions, and systems.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 18, 2021
    Inventors: Katherine PFEIFFER, Tarjei Sigurd MIKKELSEN, Michael STUBBINGTON